Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE) (EVOLVE)

This study has been completed.
Information provided by (Responsible Party):
Boston Scientific Corporation Identifier:
First received: August 16, 2010
Last updated: December 7, 2015
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)